We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




UVC Disinfection Device Inactivates COVID-19 Virus

By HospiMedica International staff writers
Posted on 07 Oct 2020
A compact counter-top ultraviolet C (UVC) unit quickly and effectively disinfects any objects placed inside it.

The Quantum Innovations (Central Point, OR, USA) FusionUV, unlike other germicidal UV devices, does not use low-power light emitting diodes (LEDs) to kill pathogens; instead, it employs two high-energy UVC bulbs to emit light in an omnidirectional fashion, thanks to the disinfection chamber’s design. More...
Industrial quality seals contain the UVC light within the unit, with an auto-shutoff switch that terminates the disinfection cycle immediately if the unit is accidentally opened. The FusionUV is being marketed by Quantum via a new company called Boon.

The FusionUV produces little heat, and is safe for use on everything from cell phones to face masks to glasses to small tools and equipment. The objects placed in the FusionUV are supported by an array of proprietary rods placed in two rows inside the box that allow UVC light to pass through, permitting total disinfection, even at the touch points. Non-porous materials, such as eyeglass frames, can be effectively treated in as little as two minutes, while porous materials like N95 masks can be disinfected in three minutes.

“We studied every detail and developed the best UVC germicidal light solution available today. This device is faster and more effective than other products and small enough to fit in nearly every environment, professional or otherwise,” said Paula Lawson, general manager of Boon. “It's a consumer-priced UVC solution in a class that previously only included boxes that begin at triple the price.”

UVC light in the 254 nm wavelength induces the formation of pyrimidine dimmers from thymine and cytosine; these dimers in turn cause disruptions in microbial DNA, making genetic replication impossible, destroying the organisms or rendering them unable to reproduce.

Related Links:
Quantum Innovations
Boon


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Portable Ventilator
Oxivent Oxi4Plus
New
Drying Cabinet
Scope Drying Cabinet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.